| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/05/2007 | EP1861378A1 N-aryl-sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents |
| 12/05/2007 | EP1861376A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 12/05/2007 | EP1861365A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 12/05/2007 | EP1861169A2 Method and composition for treating mucosal disorders |
| 12/05/2007 | EP1861124A2 Production of bioactive glycoproteins from inactive starting materials by conjugation with hydroxyalkylstarch |
| 12/05/2007 | EP1861123A2 Synergistic efect of tgf-beta blockade and immunogenic agents on tumors |
| 12/05/2007 | EP1861111A2 Methods and compositions for increasing the safety and efficacy of albumin-binding drugs |
| 12/05/2007 | EP1861109A2 Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders |
| 12/05/2007 | EP1861100A1 3 , llB-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF A PROLIFERATIVE DISEASE OR AN INFLAMMATION |
| 12/05/2007 | EP1861094A2 Histone deacetylase inhibitors sensitize cancer cells to epidermal growth factor inhibitors |
| 12/05/2007 | EP1861091A1 Compounds having lipid lowering properties |
| 12/05/2007 | EP1861086A2 Anti-proliferative combination therapy comprising satraplatin or jm118 and a taxane |
| 12/05/2007 | EP1861077A1 Non invasive method for prevention and treatment of cancer |
| 12/05/2007 | EP1861072A2 Nanocells for diagnosis and treatment of diseases and disorders |
| 12/05/2007 | EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors |
| 12/05/2007 | EP1501522A4 Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents |
| 12/05/2007 | EP1492876B1 Cationic amphiphiles for intracellular delivery of therapeutic molecules, composition, process and use thereof |
| 12/05/2007 | EP1433479B1 Appetite-stimulating agents and remedies for anorexia |
| 12/05/2007 | EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1368318B1 Calcilytic compounds |
| 12/05/2007 | EP1263752B1 Lpa receptor agonists and antagonists and methods of use |
| 12/05/2007 | EP1223976B1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 12/05/2007 | EP1208085B1 Benzanilides as potassium channel openers |
| 12/05/2007 | EP1173252B1 Products for brachytherapy and methods for their production |
| 12/05/2007 | EP1137642B1 Bis-sulfonamides |
| 12/05/2007 | EP0918754B1 Anthranilic acid diamides derivatives, their preparation and pharmaceutical use as anti-gastrin agents |
| 12/05/2007 | EP0760675B2 Compositions comprising dna damaging agents and p53 |
| 12/05/2007 | CN101084238A Receptor selectivity lymphotoxin derivates |
| 12/05/2007 | CN101084232A Antiviral oligonucleotides |
| 12/05/2007 | CN101084218A Imidazotriazines as protein kinase inhibitors |
| 12/05/2007 | CN101084217A Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds |
| 12/05/2007 | CN101084208A Aromatic amides as inhibitors of c-fms kinase |
| 12/05/2007 | CN101084204A Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC) |
| 12/05/2007 | CN101084013A Cancerous disease modifying antibodies |
| 12/05/2007 | CN101084012A Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 12/05/2007 | CN101083991A Use of diketodithiopiperazine antibiotics for the preparation of antiangiogenic pharmaceutical compositions |
| 12/05/2007 | CN101083990A Compositions and methods for disruption of brca2-rad51 interaction |
| 12/05/2007 | CN101083989A Use of thiazolidinone derivatives as antiangiogenic agents |
| 12/05/2007 | CN101083983A Indole derivatives with antitumor activity |
| 12/05/2007 | CN101083980A Use of targeted oxidative therapeutic formulation in treatment of cancer |
| 12/05/2007 | CN101083299A Unsymmetrical Unsymmetrical phthalocyanine material and method for making same |
| 12/05/2007 | CN101082043A Polyethylene glycol modified L-asparaginyl amine enzyme |
| 12/05/2007 | CN101082042A Application of artificial reconstructed defect type human 3-type adenovirus |
| 12/05/2007 | CN101081871A Protein transduction field 4-apopain fusion protein (PTD4-Apoptin) and preparation method and application thereof |
| 12/05/2007 | CN101081870A Antineoplastic biological medicament PTD4-GFP-Apoptin fusion protein and preparation method thereof |
| 12/05/2007 | CN101081848A Novel polyenes and preparation method and usage thereof |
| 12/05/2007 | CN101081846A Quinazoline derivative and preparation method and usage thereof |
| 12/05/2007 | CN101081841A Novel 2'-alpha-hydroxyalkyl taxone compound and preparation method thereof |
| 12/05/2007 | CN101081315A Medical devices containing rapamycin analogs and method for forming same |
| 12/05/2007 | CN101081301A Medicinal composition containing pemetrexed |
| 12/05/2007 | CN101081292A Method for preparation of detumescence powder detoxifcation pellet |
| 12/05/2007 | CN101081291A Medicine for treating cancer |
| 12/05/2007 | CN101081290A Chinese medicinal material preparation for relieving pain |
| 12/05/2007 | CN101081284A Chinese medicinal materials preparation for treating and preventing tumor |
| 12/05/2007 | CN101081240A Medicinal composition of oxymatrine and polysaccharide |
| 12/05/2007 | CN101081238A Gene therapy for preventing and curing highly pathogenic bird flu and enteron disease |
| 12/05/2007 | CN101081228A Medicine composition for treating and preventing stomach and intestine tumor |
| 12/05/2007 | CN101081225A Medicinal composition for preventing and curing stomach and intestine tumor through epigenetic modification |
| 12/05/2007 | CN101081219A Composition containing taxane genus compound, the method for preparing the same and the use thereof |
| 12/05/2007 | CN101081218A Rapid-disintegrated oral film and method for making same |
| 12/05/2007 | CN101081209A Anticancer composition containing tyrosine kinase restraining agent and taxane |
| 12/05/2007 | CN101081208A Slow-release injection containing tyrosine kinase restraining agent and platinum compound |
| 12/05/2007 | CN101081207A Medicine composition containing tyrosine kinase restraining agent |
| 12/05/2007 | CN101081206A Anti-cancer medicine composition containing tyrosine kinase restraining agent |
| 12/05/2007 | CN101081049A Green grape health tea |
| 12/05/2007 | CN100352929C Bitarget fibroblast growth factor acceptor and transgene carrier of integrated element |
| 12/05/2007 | CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/05/2007 | CN100352922C SiRAN and expression carrier for inhibiting human VEGF gene expression and their pharmaceutical use |
| 12/05/2007 | CN100352921C Compositions and methods for identifying antigens which elicit an immune response |
| 12/05/2007 | CN100352843C Kdr peptides and vaccines comprising the same |
| 12/05/2007 | CN100352840C Nucleus factor-kB p50 subunit combination peptide, preparation and application thereof |
| 12/05/2007 | CN100352838C Interfusion protein of antineoplastic genetic engineering composed of target short peptide of receptor of epidermal growth factor and Lidamycin |
| 12/05/2007 | CN100352831C Burnet general saponin extract , its preparation method and use |
| 12/05/2007 | CN100352828C SMAD4 gene expression-inhibiting SiRNA, its encoding sequence and application |
| 12/05/2007 | CN100352810C Fumagillol derivatives and processes for preparing the same |
| 12/05/2007 | CN100352807C Chemical compounds |
| 12/05/2007 | CN100352512C Recombinant human co-stimulatory molecule bacilli-calmette-guerin strain and process for making same |
| 12/05/2007 | CN100352510C Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| 12/05/2007 | CN100352501C Cripto blocking antibodies and uses thereof |
| 12/05/2007 | CN100352494C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 12/05/2007 | CN100352493C Method of treating tumors |
| 12/05/2007 | CN100352446C Medicinal compositions comprising n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide and further cytostatics |
| 12/05/2007 | CN100352441C Combination therapy for the treatment of cancer |
| 12/05/2007 | CN100352430C Self microemulsifying preparation of curcumin and its preparing process |
| 12/05/2007 | CN100352426C Method for preparing polymer micelle pharmaceutical preparation containing drug for injection |
| 12/04/2007 | US7304144 Antibodies binding to human TSLP Polypeptides |
| 12/04/2007 | US7304090 Using fluorescein; polycystic kidney disease, diarrhea, antiarrhythmia agents, antitumor agents, contraceptice |
| 12/04/2007 | US7304089 Preparation for improved dietary utilisation |
| 12/04/2007 | US7304083 2-iminoimidazole derivatives (2) |
| 12/04/2007 | US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents |
| 12/04/2007 | US7304078 Thrombosis; cardiovascular disorders; restenosis; hypotensive agents; antiarrhythmia agents; antiinflamamtroy agents; central nervous system disorders |
| 12/04/2007 | US7304071 stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant; 2-amino-4-(p-aminocarbonyl)phenyl-substituted pyrimidine compounds |
| 12/04/2007 | US7304066 Pyridyl cyanoguanidine compounds |
| 12/04/2007 | US7304063 Inhibitors of Akt activity |
| 12/04/2007 | US7304061 4-(5-Methyl-2-phenyl-pyrimidin-4-yl)-1H-pyrrole-2 carboxylic acid (2-hydroxy-1-(S)-phenyl-ethyl)-amide; Mitogen-activated protein kinase inhibitor; anticarcinogenic, antiinflammatory agent,neurodegenerative disorders, restenosis, antidiabetic, antiallergen, and cardiovascular disease |
| 12/04/2007 | US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment |
| 12/04/2007 | US7304059 Substituted quinazolin-4-ylamine analogues |
| 12/04/2007 | US7304054 Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals |
| 12/04/2007 | US7304053 Glycoprotein-mediated MDR |
| 12/04/2007 | US7304046 Phosphoramide compounds |